Section 402 – Cannabinoid sales and use authorized.

• (1) The sale or use of a cannabinoid product is prohibited:
  • (a) except as provided in this chapter; or
  • (b) unless the United States Food and Drug Administration approves the product.

• (2) The department shall keep a list of registered cannabinoid products that the department has determined, in accordance with Section 4-41-403, are safe for human consumption.

• (3)
  • (a) A person may sell or use a cannabinoid product that is in the list of registered cannabinoid products described in Subsection (2).
  • (b) An individual may use cannabidiol or a cannabidiol product that is not in the list of registered cannabinoid products described in Subsection (2) if:
    • (i) the individual purchased the product outside the state; and
    • (ii) the product’s contents do not violate Title 58, Chapter 37, Utah Controlled Substances Act.

• (4) Any marketing for a cannabinoid product shall include a notice to consumers that the product is hemp or CBD and is not cannabis or medical cannabis, as those terms are defined in Section 26-61a-102.

Amended by Chapter 290, 2022 General Session
Amended by Chapter 12, 2020 General Session